Smart drug delivery through DNA/magnetic nanoparticle gates.

Mesoporous silica nanoparticles can be modified to perform on-demand stimuli-responsive dosing of therapeutic molecules. The silica network was loaded with iron oxide superparamagnetic nanocrystals, providing the potential to perform targeting and magnetic resonance imaging. Single-stranded DNA was immobilized onto the material surface. The complementary DNA sequence was then attached to magnetic nanoparticles. The present work demonstrates that DNA/magnetic nanoparticle conjugates are able to cap the pores of the magnetic silica particles upon hybridization of both DNA strands. Progressive double-stranded DNA melting as a result of temperature increase gave rise to uncapping and the subsequent release of a mesopore-filled model drug, fluorescein. The reversibility of DNA linkage results in an "on-off" release mechanism. Moreover, the magnetic component of the whole system allows reaching hyperthermic temperatures (42-47 °C) under an alternating magnetic field. This feature leaves open the possibility of a remotely triggered drug delivery. Furthermore, due to its capacity to increase the temperature of the surrounding media, this multifunctional device could play an important role in the development of advanced drug delivery systems for thermochemotherapy against cancer.

[1]  Jeffrey I. Zink,et al.  Photo-Driven Expulsion of Molecules from Mesostructured Silica Nanoparticles , 2007 .

[2]  V. S. Lin,et al.  Fine-tuning the degree of organic functionalization of mesoporous silica nanosphere materials via an interfacially designed co-condensation method. , 2005, Chemical communications.

[3]  M. Vallet‐Regí,et al.  Magnetic mesoporous silica spheres for hyperthermia therapy. , 2010, Acta biomaterialia.

[4]  P. Wust,et al.  The cellular and molecular basis of hyperthermia. , 2002, Critical reviews in oncology/hematology.

[5]  E. Alocilja,et al.  Fluorescent bio-barcode DNA assay for the detection of Salmonella enterica serovar Enteritidis. , 2009, Biosensors & bioelectronics.

[6]  Weihong Tan,et al.  Immobilization of oligonucleotides onto silica nanoparticles for DNA hybridization studies , 2002 .

[7]  M. Vallet‐Regí,et al.  Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting , 2007 .

[8]  George C Schatz,et al.  What controls the melting properties of DNA-linked gold nanoparticle assemblies? , 2000, Journal of the American Chemical Society.

[9]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Overgaard,et al.  Effect of hyperthermia on malignant cells in vivo: A review and a hypothesis , 1977, Cancer.

[11]  J. Fraser Stoddart,et al.  Supramolecular nanovalves controlled by proton abstraction and competitive binding , 2006 .

[12]  Galen D. Stucky,et al.  MESOPOROUS SILICATE SEQUESTRATION AND RELEASE OF PROTEINS , 1999 .

[13]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[14]  Jinwoo Cheon,et al.  Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology , 2009 .

[15]  P. Wright,et al.  Enzyme immobilisation using siliceous mesoporous molecular sieves , 2001 .

[16]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[17]  J. F. Stoddart,et al.  pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. , 2008, Angewandte Chemie.

[18]  R. Sharma,et al.  Newer nanoparticles in hyperthermia treatment and thermometry , 2009 .

[19]  Erkki Ruoslahti,et al.  Remotely Triggered Release from Magnetic Nanoparticles , 2007 .

[20]  Jeffrey I. Zink,et al.  Versatile Supramolecular Nanovalves Reconfigured for Light Activation , 2007 .

[21]  Hsian-Rong Tseng,et al.  An operational supramolecular nanovalve. , 2004, Journal of the American Chemical Society.

[22]  P K Gupta,et al.  Drug targeting in cancer chemotherapy: a clinical perspective. , 1990, Journal of pharmaceutical sciences.

[23]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.

[24]  K. Unger,et al.  The synthesis of micrometer‐ and submicrometer‐size spheres of ordered mesoporous oxide MCM‐41 , 1997 .

[25]  Jeffrey I Zink,et al.  Light-activated nanoimpeller-controlled drug release in cancer cells. , 2008, Small.

[26]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[27]  M. Vallet‐Regí,et al.  MCM-41 Organic Modification as Drug Delivery Rate Regulator , 2003 .

[28]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[29]  M. Vallet‐Regí,et al.  Mesoporous magnetic microspheres for drug targeting , 2008 .

[30]  Hsian-Rong Tseng,et al.  A reversible molecular valve. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Chulhee Kim,et al.  Photoresponsive cyclodextrin-covered nanocontainers and their sol-gel transition induced by molecular recognition. , 2009, Angewandte Chemie.

[32]  F. Jotterand.  Nanomedicine: how it could reshape clinical practice. , 2007, Nanomedicine.

[33]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .

[34]  K. Hidajat,et al.  Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[35]  E. Johansson,et al.  Light-activated functional mesostructured silica , 2008 .

[36]  R. Langer,et al.  Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.

[37]  Larry A. Sklar,et al.  Control of Molecular Transport Through Stimuli‐Responsive Ordered Mesoporous Materials , 2003 .

[38]  Cari D. Pentecost,et al.  Construction of a pH-driven supramolecular nanovalve. , 2006, Organic letters.

[39]  S. Loening,et al.  Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .

[40]  Jan J. Heimans,et al.  Neurotoxic Complications of Chemotherapy in Patients with Cancer , 2012, Drugs.

[41]  Masahiro Fujiwara,et al.  Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.

[42]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[43]  Brian G. Trewyn,et al.  Morphological Control of Room-Temperature Ionic Liquid Templated Mesoporous Silica Nanoparticles for Controlled Release of Antibacterial Agents , 2004 .

[44]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[45]  Hung-Ting Chen,et al.  Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. , 2007, Accounts of chemical research.

[46]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[47]  R. Martínez‐Máñez,et al.  Dual aperture control on pH- and anion-driven supramolecular nanoscopic hybrid gate-like ensembles. , 2008, Journal of the American Chemical Society.

[48]  M. Dewhirst,et al.  Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. , 2000, Cancer research.

[49]  J. Lahann,et al.  Smart nanomaterials. , 2008, ACS nano.

[50]  J. F. Stoddart,et al.  Design and optimization of molecular nanovalves based on redox-switchable bistable rotaxanes. , 2007, Journal of the American Chemical Society.

[51]  María Vallet-Regí,et al.  Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. , 2006, Journal of the American Chemical Society.

[52]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[53]  Ashutosh Chilkoti,et al.  Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. , 2004, Analytical chemistry.

[54]  Sang Cheon Lee,et al.  Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. , 2007, Angewandte Chemie.

[55]  Victor S-Y Lin,et al.  Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.

[56]  Tapas Sen,et al.  Surface modification of magnetic nanoparticles with alkoxysilanes and their application in magnetic bioseparations. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[57]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.